GLP‑1 Atlas

Low blood sugar on a GLP-1

Uncommon on these medicines alone, and genuinely likely in combination with insulin or a sulfonylurea. Knowing which situation you are in matters.

The short version

  • Alone, these medicines rarely cause hypoglycaemia — they amplify insulin release only when glucose is already high.
  • Combined with insulin or a sulfonylurea, the risk is real and doses of those medicines are often reduced.
  • Symptoms: shakiness, sweating, a racing heart, confusion, sudden hunger, irritability.
  • Treat with fast-acting carbohydrate, recheck after 15 minutes, then eat something lasting.

This is a question with two completely different answers depending on what else you take, and the two get conflated constantly.

Why they rarely cause lows alone

GLP-1 amplifies insulin release in a glucose-dependent way. When blood glucose is elevated, the effect is strong. When glucose is normal or low, it does very little.

That property is what makes this class behave so differently from insulin itself, which lowers glucose regardless of where it started. It is why hypoglycaemia is uncommon in people taking a GLP-1 without other glucose-lowering medicines — and why someone taking one for weight management, without diabetes, is unlikely to encounter it.

Where the risk actually is

The picture changes entirely in combination.

Insulin lowers glucose whatever the starting point. Adding a GLP-1 lowers it further, and the insulin dose that was correct before may now be too much. This is why prescribers commonly reduce insulin when starting a GLP-1, and adjust again during escalation.

Sulfonylureas — gliclazide, glimepiride, glipizide and others — stimulate insulin release regardless of glucose level. The same logic applies, and dose reduction is standard.

If you take insulin or a sulfonylurea and were not given a plan for adjusting it when you started a GLP-1, ask. This is a routine part of starting and should not be left to chance. It is also worth revisiting at every dose increase, not only at the beginning.

Two further contributors are specific to this class. Eating markedly less than before means less carbohydrate arriving to match a medication dose set for a larger intake. And a slower stomach means carbohydrate that does arrive gets there later than the timing of a rapid-acting insulin assumed.

Recognising a low

Symptoms, roughly in the order they appear.
StageWhat you notice
EarlyShakiness, sweating, a racing or pounding heart, sudden hunger, tingling lips, anxiety without a cause
DevelopingDifficulty concentrating, irritability out of proportion, blurred vision, weakness, slurred speech
SevereConfusion, inability to treat yourself, seizure, loss of consciousness — needs help from someone else

Two complications are worth knowing. Some of the early symptoms — shakiness, a racing heart, sudden hunger — overlap with anxiety and with ordinary GLP-1 side effects, which makes them easy to misattribute. And people who have had diabetes for many years can lose the early warning symptoms altogether, a condition called hypoglycaemia unawareness. If that applies to you, monitoring matters more than sensation.

Treating one

The standard approach is simple and worth having by heart:

  1. Take 15–20 g of fast-acting carbohydrate. Glucose tablets, a small glass of fruit juice or regular soft drink. Not chocolate — fat slows absorption, and that is the opposite of what you need.
  2. Wait 15 minutes and recheck if you can measure.
  3. Repeat if it is still low.
  4. Then eat something longer-lasting — carbohydrate with protein — to stop it recurring.

One practical note specific to this class: because your stomach empties more slowly, a solid source may act more slowly than you expect. Liquid glucose is the more reliable choice.

Severe hypoglycaemia is an emergency. If someone cannot treat themselves, is confused, or is unconscious, do not give them anything by mouth. Use glucagon if it is available and you know how, and call emergency services. If you are at risk of severe lows, make sure the people around you know where your glucagon is and how to use it.

Reducing the risk

  • Have the dose conversation before you start, and again at each increase.
  • Monitor more often during escalation, when both your medication level and your eating are changing.
  • Do not skip meals if you take insulin or a sulfonylurea, even when you are not hungry. This is the most common cause of an avoidable low on this treatment, because appetite suppression makes skipping feel natural.
  • Be careful with alcohol. It suppresses the liver's glucose release for hours afterwards. More here.
  • Carry treatment. Glucose tablets, always, in the same pocket.

If you do not have diabetes

Taking a GLP-1 for weight management without diabetes and without other glucose-lowering medicines, you are unlikely to experience hypoglycaemia. If you do get repeated symptoms that look like lows, that is worth investigating rather than dismissing — not because this class commonly causes it, but because something else may be going on.

Telling a low from a side effect

Several early hypoglycaemia symptoms overlap with the ordinary experience of this treatment — a racing heart, sudden hunger, feeling shaky and unwell. That overlap is why people on insulin or a sulfonylurea are advised to measure rather than interpret.

Two distinctions help. Ordinary GLP-1 nausea does not come with sweating and a pounding heart, and it does not resolve within fifteen minutes of taking glucose. A low does both. If you can measure, measure; if you cannot and you are unsure, treat it as a low — the cost of being wrong in that direction is a sugary drink.

Sources

  1. US Prescribing Information for the products in this class — hypoglycaemia in combination with insulin secretagogues or insulin.
  2. Clinical guidance on the recognition and treatment of hypoglycaemia.

Related

  • Who should not take a GLP-1 — The absolute exclusions, the conditions that require caution, and the medicines that need rethinking before you start.
  • Pancreatitis: what to watch for — Rare, serious, and easy to dismiss when nausea and abdominal discomfort have become normal. How to tell the difference.
  • Drug interactions on a GLP-1 — A slower stomach changes how every oral medicine is absorbed. For most that is irrelevant — for a handful it is not, and those are worth knowing by name.
  • Surgery, endoscopy and anaesthesia — A stomach that empties slowly may still hold food after a standard fast. This is the interaction people forget, and the one with the sharpest consequences.

Which medicine you are on

Everything above applies across the class, because it comes from a shared mechanism. The numbers that differ — dose ladders, missed-dose windows, in-use storage periods, half-lives — differ by product, sometimes substantially. Each medicine has its own reference here:

Ozempic · Wegovy · Mounjaro · Zepbound · Rybelsus · Saxenda · Victoza · Trulicity · all medicines

How this page is sourced. Figures come from manufacturers' approved labelling and from published clinical and pharmacokinetic literature. Regional labels differ, sometimes materially — where a number matters, the leaflet in your own box outranks anything written here. This site is not written or medically reviewed by clinicians, and we say so rather than implying otherwise; our editorial standards set out what that means and how corrections work.